183 related articles for article (PubMed ID: 37389795)
1. Applying Systems Thinking to Inform Decentralized Clinical Trial Planning and Deployment.
Betcheva L; Kim JY; Erhun F; Oraiopoulos N; Getz K
Ther Innov Regul Sci; 2023 Sep; 57(5):1081-1098. PubMed ID: 37389795
[TBL] [Abstract][Full Text] [Related]
2. Assessing the Financial Value of Decentralized Clinical Trials.
DiMasi JA; Smith Z; Oakley-Girvan I; Mackinnon A; Costello M; Tenaerts P; Getz KA
Ther Innov Regul Sci; 2023 Mar; 57(2):209-219. PubMed ID: 36104654
[TBL] [Abstract][Full Text] [Related]
3. Decentralized clinical trials (DCTs): A few ethical considerations.
Petrini C; Mannelli C; Riva L; Gainotti S; Gussoni G
Front Public Health; 2022; 10():1081150. PubMed ID: 36590004
[TBL] [Abstract][Full Text] [Related]
4. Opportunities and Challenges for Decentralized Clinical Trial Approaches: European Health Technology Assessment Perspective.
de Jong AJ; Shahid N; Zuidgeest MGP; Santa-Ana-Tellez Y; Hogervorst M; Goettsch W; Traore H; de Boer A; Gardarsdottir H;
Value Health; 2024 Mar; 27(3):294-300. PubMed ID: 38043711
[TBL] [Abstract][Full Text] [Related]
5. Leveraging Decentralized Clinical Trial Management Systems (dCTMS) to Advance Science: Exploring Challenges Related to the Diffusion of Innovation and Its Execution.
Rao RK
Blockchain Healthc Today; 2024; 7():. PubMed ID: 38715764
[TBL] [Abstract][Full Text] [Related]
6. The landscape of decentralized clinical trials (DCTs): focusing on the FDA and EMA guidance.
Park J; Huh KY; Chung WK; Yu KS
Transl Clin Pharmacol; 2024 Mar; 32(1):41-51. PubMed ID: 38586122
[TBL] [Abstract][Full Text] [Related]
7. Design and Execution of Sustainable Decentralized Clinical Trials.
Singh P; Burden AM; Natanegara F; Beckman RA
Clin Pharmacol Ther; 2023 Oct; 114(4):802-809. PubMed ID: 37489911
[TBL] [Abstract][Full Text] [Related]
8. Legal, Regulatory, and Practical Issues to Consider When Adopting Decentralized Clinical Trials: Recommendations From the Clinical Trials Transformation Initiative.
Apostolaros M; Babaian D; Corneli A; Forrest A; Hamre G; Hewett J; Podolsky L; Popat V; Randall P
Ther Innov Regul Sci; 2020 Jul; 54(4):779-787. PubMed ID: 32557302
[TBL] [Abstract][Full Text] [Related]
9. Decentralized Clinical Trials: Scientific Considerations Through the Lens of the Estimand Framework.
Izem R; Zuber E; Daizadeh N; Bretz F; Sverdlov O; Edrich P; Branson J; Degtyarev E; Sfikas N; Hemmings R
Ther Innov Regul Sci; 2024 May; 58(3):495-504. PubMed ID: 38315407
[TBL] [Abstract][Full Text] [Related]
10. A secondary qualitative analysis of stakeholder views about participant recruitment, retention, and adherence in decentralised clinical trials (DCTs).
Coyle J; Rogers A; Copland R; De Paoli G; MacDonald TM; Mackenzie IS;
Trials; 2022 Jul; 23(1):614. PubMed ID: 35907888
[TBL] [Abstract][Full Text] [Related]
11. Quantifying Site Burden to Optimize Protocol Performance.
Florez M; Smith Z; Olah Z; Martin M; Getz K
Ther Innov Regul Sci; 2024 Mar; 58(2):347-356. PubMed ID: 38191957
[TBL] [Abstract][Full Text] [Related]
12. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
13. Ethics review of decentralized clinical trials (DCTs): Results of a mock ethics review.
van Rijssel TI; de Jong AJ; Santa-Ana-Tellez Y; Boeckhout M; Zuidgeest MGP; van Thiel GJMW;
Drug Discov Today; 2022 Oct; 27(10):103326. PubMed ID: 35870693
[TBL] [Abstract][Full Text] [Related]
14. Opportunities and Challenges for Decentralized Clinical Trials: European Regulators' Perspective.
de Jong AJ; van Rijssel TI; Zuidgeest MGP; van Thiel GJMW; Askin S; Fons-MartÃnez J; De Smedt T; de Boer A; Santa-Ana-Tellez Y; Gardarsdottir H;
Clin Pharmacol Ther; 2022 Aug; 112(2):344-352. PubMed ID: 35488483
[TBL] [Abstract][Full Text] [Related]
15. Decentralized Clinical Trials in the Development of Drugs and Biological Products.
Robinson R; Sacks L
Ther Innov Regul Sci; 2024 Feb; ():. PubMed ID: 38305983
[TBL] [Abstract][Full Text] [Related]
16. The Ethics of Decentralized Clinical Trials and Informed Consent: Taking Technologies' Soft Impacts into Account.
van Rijssel TI; van Thiel GJMW; van Delden JJM;
Health Care Anal; 2024 May; ():. PubMed ID: 38764063
[TBL] [Abstract][Full Text] [Related]
17. Exploring the divergence in perspectives on clinical trial operations in South Korea during the COVID-19 pandemic: a comparison of a trial site and sponsors.
Kim YS; Kim A; Lee YS
Front Med (Lausanne); 2024; 11():1342184. PubMed ID: 38510454
[TBL] [Abstract][Full Text] [Related]
18. Opportunities and challenges with decentralized trials in Neuroscience.
Burger HU; Van de Casteele T; Rantell KR; Corey-Lisle P; Sfikas N; Abt M;
Biom J; 2023 Dec; 65(8):e2200370. PubMed ID: 37609878
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of methods used to conduct decentralised clinical trials.
Rogers A; De Paoli G; Subbarayan S; Copland R; Harwood K; Coyle J; Mitchell L; MacDonald TM; Mackenzie IS;
Br J Clin Pharmacol; 2022 Jun; 88(6):2843-2862. PubMed ID: 34961991
[TBL] [Abstract][Full Text] [Related]
20. Opportunities and counterintuitive challenges for decentralized clinical trials to broaden participant inclusion.
Goodson N; Wicks P; Morgan J; Hashem L; Callinan S; Reites J
NPJ Digit Med; 2022 May; 5(1):58. PubMed ID: 35513479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]